Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
-
▾0.00 (0.00%)
Last trade: 28/03, 5:58AM
Market cap
-
Market closed
Benitec Biopharma Limited has been removed from the Australian Securities Exchange official list as of 16/04/2020
Investor Presentations
Principal Activity
Benitec Biopharma Limited (BLT) is a biotechnology company focused on the development of treatments for chronic and life-threatening human conditions based on its patented gene-silencing technology, ddRNAi. BLT has also licensed ddRNAi technology and other patent estate to other biopharmaceutical companies. The Company's current focus has been on its hepatitis C therapeutic, TT-034. Former Names Queensland Opals NL (QOP), 30/04/2002; Benitec Limited (BLT), 24/11/2011
Address
1201/99 Mount St, North Sydney NSW 2060, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
-
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Support
Live Chat
Markets
Contact Us
(03) 9661 0441
clients@freshequities.com
Address
Level 16, 452 Flinders St
Melbourne VIC 3000
Australia